ARKG 04/17/2024

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
104/17/2024CRISPR THERAPEUTICS AGCRSPH171821087.44%1,705,069 (16,962) (1%)$98,825,799.24
204/17/2024TWIST BIOSCIENCE CORPTWST90184D1006.00%2,786,325 (27,709) (1%)$79,716,758.25
304/17/2024EXACT SCIENCES CORPEXAS30063P1055.50%1,144,543 (11,385) (1%)$73,090,515.98
404/17/2024RECURSION PHARMACEUTICALS-ARXRX75629V1045.13%9,007,624 (89,595) (1%)$68,187,713.68
504/17/2024SCHRODINGER INCSDGR80810D1034.60%2,465,952 (24,530) (1%)$61,056,971.52
604/17/2024IONIS PHARMACEUTICALS INCIONS4622221004.29%1,370,400 (13,629) (1%)$56,926,416.00
704/17/2024BEAM THERAPEUTICS INCBEAM07373V1054.07%2,104,765 (20,933) (1%)$54,092,460.50
804/17/2024ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.91%1,724,946 (17,160) (1%)$51,972,622.98
904/17/2024INTELLIA THERAPEUTICS INCNTLA45826J1053.87%2,358,548 (23,463) (1%)$51,439,931.88
1004/17/202410X GENOMICS INC-CLASS ATXG88025U1093.76%1,621,349 (16,126) (1%)$49,937,549.20
1104/17/2024GINKGO BIOWORKS HOLDINGS INCDNA37611X1003.57%51,859,840 (515,801) (1%)$47,373,963.84
1204/17/2024ACCOLADE INCACCD00437E1023.48%5,494,957 (54,648) (1%)$46,157,638.80
1304/17/2024CAREDX INCCDNA14167L1033.39%5,742,808 (57,123) (1%)$45,081,042.80
1404/17/2024TELADOC HEALTH INCTDOC87918A1053.29%3,326,744 (33,088) (1%)$43,680,148.72
1504/17/2024MODERNA INCMRNA60770K1072.99%382,581 (3,806) (1%)$39,708,081.99
1604/17/2024NURIX THERAPEUTICS INCNRIX67080M1032.85%2,579,730 (25,663) (1%)$37,793,044.50
1704/17/2024VEEVA SYSTEMS INC-CLASS AVEEV9224751082.76%183,131 (1,815) (1%)$36,693,958.47
1804/17/2024VERACYTE INCVCYT92337F1072.75%1,926,909 (19,162) (1%)$36,457,118.28
1904/17/2024VERTEX PHARMACEUTICALS INCVRTX92532F1002.62%88,192 (880) (1.01%)$34,762,640.64
2004/17/2024STANDARD BIOTOOLS INCLAB34385P1082.61%12,769,113 (127,006) (1%)$34,604,296.23
2104/17/2024ADAPTIVE BIOTECHNOLOGIESADPT00650F1092.14%10,347,695 (102,916) (1%)$28,456,161.25
2204/17/2024908 DEVICES INCMASS65443P1021.73%3,964,413 (39,435) (1%)$22,953,951.27
2304/17/2024INCYTE CORPINCY45337C1021.61%401,450 (3,993) (1%)$21,365,169.00
2404/17/2024VERVE THERAPEUTICS INCVERV92539P1011.59%2,956,902 (29,414) (1%)$21,112,280.28
2504/17/2024QUANTUM-SI INCQSI74765K1051.54%12,503,970 (124,366) (1%)$20,506,510.80
2604/17/2024COMPASS PATHWAYS PLCCMPS20451W1011.40%2,116,330 (21,054) (1%)$18,581,377.40
2704/17/2024ABSCI CORPABSI00091E1091.30%3,208,406 (31,911) (1%)$17,261,224.28
2804/17/2024PACIFIC BIOSCIENCES OF CALIFPACB69404D1081.24%11,783,533 (117,205) (1%)$16,496,946.20
2904/17/2024REGENERON PHARMACEUTICALSREGN75886F1071.20%17,820 (176) (1%)$15,933,574.80
3004/17/2024PRIME MEDICINE INCPRME74168J1011.18%2,978,743 (29,623) (1%)$15,697,975.61
3104/17/2024UIPATH INC – CLASS APATH90364P1051.10%754,481 (7,502) (1%)$14,644,476.21
3204/17/2024CERUS CORPCERS1570851011.02%8,056,746 (80,135) (1%)$13,535,333.28
3304/17/2024AMGEN INCAMGN0311621001.01%50,562 (506) (1.01%)$13,431,289.68
3404/17/2024BUTTERFLY NETWORK INCBFLY1241551020.75%11,060,867 (110,011) (1%)$9,954,780.30
3504/17/2024REPARE THERAPEUTICS INCRPTX7602731020.67%2,648,206 (26,334) (1%)$8,845,008.04
3604/17/2024PERSONALIS INCPSNL71535D1060.60%6,403,906 (121,361) (1.93%)$7,940,843.44
3704/17/2024NATERA INCNTRA6323071040.55%81,070 (803) (1%)$7,322,242.40
3804/17/2024GUARDANT HEALTH INCGH40131M1090.43%353,596 (3,520) (1.01%)$5,714,111.36
3904/17/2024SENTI BIOSCIENCES INCSNTI81726A1000.04%1,581,622 (15,741) (1.01%)$474,486.60
4004/17/2024Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (0) (0%)$73,041.30
4104/17/2024GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.01%147,199 (-2,652,158) (-94.74%)$147,198.69
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment